Core Viewpoint - The crisis surrounding Up Beauty Co., Ltd. continues to escalate, with significant stock price fluctuations and allegations of illegal additives in its products, particularly affecting its core brand, Han Shu [1][2][10]. Stock Performance - On December 30, Up Beauty's stock fell by 2.5%, closing at HKD 72.2, marking a total decline of over 15% over two days [1]. - The stock experienced a sharp drop on December 29, reaching a low of HKD 57, a decline of over 33% during the trading session [1]. Product Controversy - Han Shu's products were found to contain epidermal growth factor (EGF), which is not permitted in cosmetics due to safety concerns [2]. - Following the allegations, Han Shu removed the affected products from e-commerce platforms and issued a statement denying the presence of EGF in its products [2][4]. Consumer Reaction - Consumers have expressed distrust and demanded refunds, citing concerns over the safety of the products after the illegal additive allegations [4]. - Previous incidents of illegal additives in Han Shu products have raised further doubts about the brand's integrity [9]. Financial Performance - In the first half of 2025, Han Shu contributed approximately 81.4% of Up Beauty's revenue, amounting to CNY 3.344 billion, a 14.3% increase year-on-year [10]. - The company's online self-operated channel revenue reached CNY 3.421 billion, a 24.6% increase, with its share of total revenue rising from 78.4% to 83.3% [10]. Marketing Strategy - Up Beauty has heavily invested in marketing, particularly through collaborations with influencers and short dramas, leading to a significant increase in revenue [10][11]. - However, this strategy has resulted in rising marketing expenses, with the sales expense ratio increasing from 47.01% in 2022 to 56.88% in the first half of 2025, while R&D spending has decreased [11]. Strategic Shift - The company is shifting its strategic focus towards other brands, aiming for a pre-tax sales target of CNY 4.36 billion for 2026, with specific targets for brands like NEW PAGE and Anminyou [12][13]. - Concerns remain regarding the feasibility of these targets, given the current revenue performance of these brands [13].

在港股新消费板块经历从"流量狂欢"到"价值回归"的洗牌后，市场对新消费标准的考核逻辑已完成根本 性转变——从单纯追逐短期GMV增速，转向审视企业的长期运营能力、品牌韧性与科研壁垒。 作为港股美妆新消费标的代表，上美股份(02145)精准踩中了消费趋势的演进节奏：今年以来，该公司 走出一波漂亮的"翻倍"行情，年初至今的股价累计涨幅高达150%，并在年内股价突破104港元，创下上 市以来新高。 在股价不断突破的背后，更值得关注的是，上美股份正通过"多品牌矩阵、全渠道协同、研发筑优势"的 多维布局，在行业波动期实现了业绩与估值的双重突围，也为港股新消费赛道提供了一个稀缺的成长标 杆。 多品牌矩阵成型，构建全新增长体系 纵观新消费板块的早期红利，源于流量平台崛起带来的"大众市场普惠"，但随着消费分级与细分化趋势 加剧，"单品牌通吃"的时代逐渐落幕。根据2025年上半年的业绩报告，行业龙头之间已出现显著分化， 部分前期高增长的明星企业面临着严峻挑战，其背后的"单核隐忧"是重要原因。 基于对市场和行业前瞻性的预判，上美股份率先摒弃了"押注单一爆品/品牌"的旧有模式，以多品牌矩 阵精准对接不同的消费需求，完成了从"流量支撑 ...

在港股新消费板块经历从"流量狂欢"到"价值回归"的洗牌后，市场对新消费标准的考核逻辑已完成根本 性转变——从单纯追逐短期GMV增速，转向审视企业的长期运营能力、品牌韧性与科研壁垒。 作为港股美妆新消费标的代表，上美股份(02145)精准踩中了消费趋势的演进节奏：今年以来，该公司 走出一波漂亮的"翻倍"行情，年初至今的股价累计涨幅高达150%，并在年内股价突破104港元，创下上 市以来新高。 在股价不断突破的背后，更值得关注的是，上美股份正通过"多品牌矩阵、全渠道协同、研发筑优势"的 多维布局，在行业波动期实现了业绩与估值的双重突围，也为港股新消费赛道提供了一个稀缺的成长标 杆。 多品牌矩阵成型，构建全新增长体系 纵观新消费板块的早期红利，源于流量平台崛起带来的"大众市场普惠"，但随着消费分级与细分化趋势 加剧，"单品牌通吃"的时代逐渐落幕。根据2025年上半年的业绩报告，行业龙头之间已出现显著分化， 部分前期高增长的明星企业面临着严峻挑战，其背后的"单核隐忧"是重要原因。 基于对市场和行业前瞻性的预判，上美股份率先摒弃了"押注单一爆品/品牌"的旧有模式，以多品牌矩 阵精准对接不同的消费需求，完成了从"流量支撑 ...

Group 1 - The beauty and personal care sector has shown a recovery in 2025, with the SW Beauty Index rebounding after a decline from 2022 to 2024, achieving a maximum increase of over 15% and becoming a key area in new consumption [3][9][10] - The cosmetics segment is characterized by intense competition among brands, with domestic brands making significant strides in R&D and distribution, while international brands are adopting localized strategies to regain market share [3][20][25] - The medical beauty market is transitioning from a blue ocean to a red ocean, with domestic companies expected to become major competitors by focusing on affordable and specialized products [3][19][24] Group 2 - The e-commerce operation sector is undergoing a transformation, with companies like RuYuchen and Shuiyang Co. leveraging brand incubation and AI to create new growth avenues [3][19] - Key investment recommendations include domestic brands with strong channel and brand matrices such as MaoGePing, ShangMei Co., and PoLaiYa, as well as companies in the medical beauty sector like AiMeiKe and LongZi Co. [3][19][24] - The report emphasizes the importance of brand matrix construction and product innovation in the cosmetics industry, with companies like ShangMei Co. and PoLaiYa leading the way [3][31][40] Group 3 - The skincare and makeup market is expected to enter a phase of consolidation, with strong brands likely to thrive while weaker ones may struggle [23][24] - The market share of domestic brands is increasing, with a notable decline in the market share of international brands, indicating a significant opportunity for domestic players [25][30] - The report highlights the importance of adapting to changing consumer preferences and channel dynamics, with a focus on online platforms and promotional strategies to enhance brand visibility [48][52][53]

Core Viewpoint - The cosmetics industry is undergoing a strategic transformation from basic moisturizing to efficacy-driven and scientific approaches, with peptides emerging as key active ingredients in anti-aging skincare products [3][4]. Market Size and Growth Trends - The global peptide cosmetics market is rapidly growing, with projections indicating a market size of $2.566 billion in 2024, expected to reach $5.716 billion by 2031, reflecting a compound annual growth rate (CAGR) of 12.3% during the forecast period [6][8]. - In 2024, over 55 million consumers are expected to use peptide skincare products, with 68% targeting wrinkle reduction and skin tightening [9]. Regional Market Performance - The Asia-Pacific region is the largest market for peptide cosmetics, accounting for 36% of global sales, with South Korea alone selling over 12.7 million units in 2023 [10][11]. - North America follows closely, representing 34% of global sales, with the U.S. having over 16.2 million active peptide skincare users [12][13]. - Europe contributes 28% of global sales, with Germany, the UK, and France leading the market [11][12]. Segment Market Performance - Serums are the largest segment, accounting for 38% of global sales, with over 480 peptide serums launched in 2023 [15]. - Moisturizing repair creams hold a 26% market share, while anti-aging creams account for 17% [15]. - Eye creams represent 11% of the segment, with 95 peptide SKUs recorded in 2023 [15]. Sales Channel Performance - Online sales dominate the market, accounting for 46% of total sales, with over 37 million peptide products sold through e-commerce platforms in 2023 [16]. - Specialty cosmetics stores contribute 27% to global sales, while supermarkets account for 18% [16]. Capital Flow and Investment Trends - In 2023, the global peptide cosmetics market attracted over $1.12 billion in funding, primarily directed towards R&D, clinical trials, and sustainable packaging [18][19]. - North America received over $360 million in investments, focusing on biotechnology-based peptide platforms [18]. Product Innovation - Over 110 new peptide products were launched globally between 2023 and 2024, showcasing a trend towards multi-peptide formulations and precision delivery systems [20]. - Brands are increasingly integrating AI for personalized skincare solutions, with over 145 brands utilizing AI skin diagnostic systems [20]. Competitive Landscape - The competitive landscape is shifting, with L'Oréal leading the market, followed by Estée Lauder and emerging brands like Han Shu [21][22]. - Han Shu's Red Waist 2.0 series achieved remarkable sales, emphasizing innovative raw material development and effective marketing strategies [22][25]. Raw Material Market Expansion - The peptide manufacturing market is projected to reach $2.574 billion by 2025, with a CAGR of 5.4% from 2025 to 2035 [26]. - There is a growing trend towards sustainable sourcing of peptides, with plant-based peptides gaining traction [26]. Challenges and Development - High costs and stability issues remain significant challenges, with 41% of brands reporting delays in product launches due to packaging and preservation difficulties [27]. - Regulatory fragmentation is also a concern, with only 27 countries having established guidelines for peptide ingredients [27]. Conclusion - The global peptide cosmetics market is in a phase of high growth and innovation, driven by technological advancements and evolving consumer demands, with a competitive landscape characterized by both established leaders and emerging players [29][31].

Investment Rating - The report upgrades the investment rating to "Buy" for the company [5] Core Views - The company is transitioning towards a multi-brand beauty group, with a focus on operational efficiency and data-driven strategies to enhance growth certainty [14][15] - The main brand, Han Shu, has shown significant revenue growth through effective channel strategies, particularly on Douyin, and is expected to continue this trend [5][15] - The company has successfully launched new brands and product lines, contributing to its revenue and market presence [5][14] Summary by Sections 1. Transition to a Multi-Brand Beauty Group - The company is evolving into a multi-brand beauty group, with Han Shu as its main brand, achieving revenue of 41.1 billion RMB in 25H1, a year-on-year increase of 17.3% [14] - The net profit for the same period was 5.6 billion RMB, reflecting a year-on-year growth of 34.7% [14] 2. Channel Strategy - The company has leveraged its historical experience to capitalize on sales and marketing opportunities, particularly through Douyin, which has become a key growth driver [24][31] - The transition from B2B to B2C has led to a significant increase in online self-operated channels, with Douyin's contribution to revenue rising sharply [19][22] 3. Product Development - The company has focused on developing high-quality products with competitive pricing, exemplified by the success of the "Red Waist" series, which has become a best-seller [52][54] - The introduction of the "X Peptide" series has also shown promising sales, with total sales exceeding 200 million RMB [61] 4. Operational Efficiency - The company's operational strategies have shifted towards a platform model, emphasizing top-tier resources and talent to enhance brand development [5][14] - The focus on data-driven decision-making has improved the company's ability to respond to market trends and consumer preferences [31][32]

Core Viewpoint - The company, Up Beauty Co., has demonstrated strong financial performance in the first half of the year, with significant year-on-year growth in both revenue and net profit, reflecting its robust market position and operational efficiency [1][7]. Financial Performance - Up Beauty Co. achieved a revenue of 4.108 billion yuan, representing a year-on-year increase of 17.3%, and a net profit of 556 million yuan, up 34.7% year-on-year, indicating a strong growth trajectory [1]. - The gross profit reached 3.12 billion yuan, with a gross margin of 75.5%, which is an increase of 1.7 percentage points from the previous period, showcasing high profitability [1]. - The earnings per share were 1.32 yuan, a 30.7% increase year-on-year, with a mid-term dividend of 0.5 yuan per share, reflecting solid cash flow and a commitment to shareholder returns [7]. Market Position and Growth Strategy - The new consumption sector in the Hong Kong stock market has become a focal point for capital, with Up Beauty Co. positioned as a leading player benefiting from the rising trend of self-care consumption and emotional value in spending [1][2]. - The company employs a multi-brand strategy that enhances market coverage and product competitiveness, with its main brand, Han Shu, achieving a revenue of 3.344 billion yuan, a 14.3% increase year-on-year [8][9]. - The brand newpage has also shown remarkable growth, with a revenue of 397 million yuan, marking a 146.5% increase year-on-year, indicating strong market penetration [9]. Research and Development - Up Beauty Co. invested over 103 million yuan in R&D, a 31.7% increase year-on-year, which constitutes 2.5% of its revenue, and holds nearly 200 patents, enhancing its innovation capabilities [13]. - The establishment of the Han Shu Translational Medicine Fund aims to strengthen the integration of research and practical application, further supporting product innovation [13]. Future Growth Potential - The company is well-positioned to benefit from the ongoing transformation in the cosmetics industry, with domestic brands capturing 55% of the market share, indicating a shift towards local products [14][15]. - Up Beauty Co. plans to launch new brands, including high-end anti-aging and makeup lines, leveraging strong partnerships and its existing R&D capabilities to meet diverse consumer needs [18][21]. - The company is also expanding its global footprint, particularly in Southeast Asia, which presents new growth opportunities [22].

Core Viewpoint - The article highlights the strong performance and growth potential of the beauty company, Shiseido Holdings (上美股份), driven by a multi-brand strategy, innovative product development, and a comprehensive sales channel approach, amidst a rising trend of young consumers prioritizing experience and value in their purchasing decisions [1][2][11]. Financial Performance - In the first half of 2025, Shiseido Holdings reported total revenue of approximately 4.108 billion RMB, a year-on-year increase of 17.3% [2] - The net profit reached about 555.6 million RMB, reflecting a 34.7% increase compared to the previous year [2] - Gross profit was approximately 3.102 billion RMB, with a year-on-year growth of 15.8%, resulting in a gross margin of 75.5%, up 1.7 percentage points from the previous period [2] - Basic earnings per share for the first half of 2025 were 1.32 RMB, a 30.7% increase year-on-year [2] Multi-Brand Strategy - The company's strong performance is attributed to its deepening multi-brand strategy, with its main brand, Han Shu (韩束), achieving revenue of approximately 3.344 billion RMB, a 14.3% increase year-on-year [3] - Han Shu's star product, the Red Waist series, sold over 15 million units, establishing itself as a national skincare staple [3] - The new brand, Newpage (一页), showed remarkable growth with revenue of 397 million RMB, a 146.5% increase year-on-year, indicating its successful entry into the baby care market [5] Sales Channel Development - Shiseido Holdings has effectively implemented a comprehensive sales channel strategy, with Han Shu ranking first in monthly GMV on Douyin in the first half of 2025 [10] - The brand has also seen significant growth across various e-commerce platforms, including Tmall, Vipshop, Pinduoduo, and Kuaishou, creating a robust sales ecosystem [10] Research and Development - The company invested over 103 million RMB in R&D in the first half of 2025, a 31.7% increase year-on-year, resulting in nearly 200 patents and several publications in global core journals [11] - The establishment of the "Han Shu Translational Medicine Fund" signifies the company's commitment to integrating academic and medical resources to enhance product innovation [12] International Expansion - Shiseido Holdings is actively pursuing international growth, particularly in Southeast Asia, aiming to elevate its brand from a "Chinese brand" to a "global brand" [13] - The company's international strategy is expected to open new growth avenues and enhance its global market presence [13]

Core Viewpoint - The article highlights the strong performance and growth potential of the beauty company, Shiseido Holdings (上美股份), driven by a multi-brand strategy, innovative product development, and a comprehensive sales channel approach, amidst a rising trend of young consumers prioritizing experience and value in their purchasing decisions [1][2][12]. Financial Performance - In the first half of 2025, Shiseido Holdings reported total revenue of approximately 4.108 billion RMB, a year-on-year increase of 17.3% [2] - The net profit reached about 555.6 million RMB, up 34.7% compared to the previous year, with a gross profit of approximately 3.102 billion RMB, reflecting a 15.8% increase [2] - The gross margin improved to 75.5%, marking a 1.7 percentage point increase from the previous period, indicating high-quality core business development [2] Multi-Brand Strategy - The company's strong performance is attributed to its deepening multi-brand strategy, with its main brand, Han Shu (韩束), achieving revenue of approximately 3.344 billion RMB, a 14.3% increase year-on-year [3] - Han Shu's star product, the Red Waist series, sold over 15 million units, establishing itself as a national skincare staple, while the X Peptide Super Frequency series surpassed 200 million RMB in sales [3][5] - The brand has successfully expanded into various product categories, achieving top sales in body lotion, shampoo, masks, and facial cleansers, transitioning from a facial skincare brand to a comprehensive care expert [3][5] Emerging Brands - The emerging brand, Newpage (一页), demonstrated significant growth, with revenue of 397 million RMB, a remarkable 146.5% increase year-on-year, and online sales exceeding the total for 2024 [5][6] - Newpage's flagship product, the Baby Comfort Cream, sold 330,000 units during the 618 shopping festival, ranking first in the Tmall and Douyin categories for baby creams [6] Sales Channels - The company has established a robust omnichannel sales strategy, with Han Shu ranking first in GMV on Douyin in the first half of 2025, contributing to significant growth across various e-commerce platforms [11] - This comprehensive sales ecosystem reflects the company's deep understanding of consumer behavior and market trends, enhancing brand loyalty and driving high potential across its product lines [11] Research and Development - Shiseido Holdings invested over 103 million RMB in R&D in the first half of 2025, a 31.7% increase year-on-year, resulting in nearly 200 patents and publications in global core journals [12][13] - The establishment of the "Han Shu Translational Medicine Fund" signifies the company's commitment to integrating academic and medical resources to accelerate product innovation [13] International Expansion - The company is actively pursuing international growth, particularly in Southeast Asia, aiming to enhance its global brand presence and transition from a "Chinese brand" to a "global brand" [14] - This strategic move is expected to open new growth avenues and increase the company's international influence [14] Conclusion - The impressive performance of Shiseido Holdings in the first half of 2025 is a result of its deepened multi-brand strategy, enhanced product capabilities, and optimized channel efficiency, positioning it as a key player in the domestic beauty market [14]

Investment Rating - The report gives a "Buy" rating for the company, marking its first coverage [1]. Core Insights - The company is expected to achieve stable growth over the next three years through its "2+2+2" strategy, which focuses on skincare, hair care, and maternal and infant care, supported by a rich reserve of new brands [3][4]. - The main brand, Han Shu, maintains a leading position in the anti-aging skincare sector, with significant expansion into men's and color cosmetics, while new brands like NEWPAGE are rapidly gaining traction in the infant skincare market [10][11]. - The company's revenue is projected to grow significantly, with total revenue expected to reach 67.9 billion yuan in 2024, a year-on-year increase of 61.2%, and net profit expected to reach 7.8 billion yuan, up 69.4% [10][11]. Summary by Sections 1. Company Overview - The company is a leading multi-brand cosmetics enterprise in China, focusing on skincare, maternal and infant care, and hair care products. It has successfully built a brand matrix that includes popular brands like Han Shu and NEWPAGE [17]. - The company has experienced strong revenue growth, with a compound annual growth rate (CAGR) of 19.0% from 2020 to 2024, driven by the explosive growth of its main brand Han Shu [31]. 2. Brand Strategy - The "2+2+2" strategy integrates two major brands in skincare, two in maternal and infant care, and two in hair care, creating a diversified brand matrix that meets various consumer needs [42]. - Han Shu accounts for approximately 82.3% of total revenue, with a strong performance in the anti-aging market, while NEWPAGE has emerged as a significant growth driver in the infant skincare segment [46][60]. 3. Financial Performance - The company’s revenue is projected to grow from 42.1 billion yuan in 2023 to 67.9 billion yuan in 2024, with net profit expected to increase from 1.3 billion yuan to 7.8 billion yuan during the same period [31][11]. - The gross margin has improved significantly, rising from 60.9% in 2019 to 75.2% in 2024, reflecting the success of the high-end product strategy [33]. 4. Sales Channels - Online sales have become a major revenue source, with the online channel accounting for 90.5% of total revenue in 2024, driven by the strong performance of Han Shu and the rapid growth of NEWPAGE [37]. - The company has increased its self-operated sales proportion from 46.7% in 2020 to 78.2% in 2024, indicating a shift towards more direct sales strategies [37]. 5. Future Growth Drivers - The company is expanding its brand matrix with new brands targeting specific market segments, such as the high-end infant skincare market with NEWPAGE and the maternal care market with Red Elephant [60][68]. - The focus on innovation and research is expected to drive future growth, particularly in the clean beauty segment with brands like One Leaf [68].